![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Combination Containing MK-5172 (HCV NS3 protease inhibitor) and MK-8742 (HCV NS5A inhibitor) Demonstrates High Barrier to Resistance in HCV Replicon
|
|
|
Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
Frederick Lahser, Rong Liu, Karin Bystol,
Ellen Xia, Richard Raubertas,
Ernest Asante-Appiah, Anita Y. M. Howe
![AASLD1.gif](../images/111312/111312-10/AASLD1.gif)
![AASLD2.gif](../images/111312/111312-10/AASLD2.gif)
![AASLD3.gif](../images/111312/111312-10/AASLD3.gif)
![AASLD4.gif](../images/111312/111312-10/AASLD4.gif)
![AASLD5.gif](../images/111312/111312-10/AASLD5.gif)
![AASLD6.gif](../images/111312/111312-10/AASLD6.gif)
![AASLD7.gif](../images/111312/111312-10/AASLD7.gif)
![AASLD8.gif](../images/111312/111312-10/AASLD8.gif)
![AASLD9.gif](../images/111312/111312-10/AASLD9.gif)
![AASLD10.gif](../images/111312/111312-10/AASLD10.gif)
![AASLD11.gif](../images/111312/111312-10/AASLD11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|